₹2,103.10
+₹5.80 (+0.28%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹12,831 Cr
P/E
64.47
ROE
24.79%
ROCE
27.13%
About Corona Remedies Ltd
Corona Remedies is primarily engaged in the business of manufacturing, trading and marketing of Pharmaceutical products.
Founded
2004
CEO
KIRTIKUMAR LAXMIDAS MEHTA
Employees
5,686
HQ
Ahmedabad, Gujarat
About Corona Remedies Ltd
Corona Remedies is primarily engaged in the business of manufacturing, trading and marketing of Pharmaceutical products.
Founded:2004
CEO:KIRTIKUMAR LAXMIDAS MEHTA
Employees:5,686
HQ:Ahmedabad, Gujarat
Finished Products
1Sale of Products
₹2,594.30Cr2Sale of Services
₹2.69Cr3Export Incentive
₹1.78Cr4Other Operating Income
₹0.66Cr5Scrap sale
₹0.17CrRaw Materials
1Purchase
₹308.35Cr2Raw Material Consumed
₹205.80CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,270
52W Low
₹1,337
Volume14.50K
Avg VolumeN/A
BetaN/A
Dividend Yield0.48%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
64.47x
Valuation
P/B Ratio
17.18x
Valuation
EPS
₹32.54
Valuation
Dividend Yield
0.48%
Valuation
ROE
24.79%
Profitability
ROCE
27.13%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
96.3%
International
3.7%
In India96.3%
Outside India3.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.22x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
11.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.